Anagestone acetate
- Level
- Commodity
- Parent
- 51351500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351521This classification denotes a therapeutic progestin with the molecular formula C24H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GNT396G9QT, chemically known as pregn-4-en-20-one, 17-hydroxy-6alpha-methyl-, acetate (8ci) but more generally known as anagestone acetate, which bears US NIH Compound Identifier 18443. European Medicines Agency schedules Anagestone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00522MIG. Most nations, for tariff and trade purposes, schedule anagestone acetate under HS 29372300 and SITC 54153. As of Q4 2014, ANAGESTONE ACETATE remains US FDA's Preferred Term for this commodity. Anagestone acetate bears US NLM identifiers UMLS ID C2698107 and NCI Concept Code C76302. SMILES: C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CCCC4)C.
Same parent
Under 51351500 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.